Report - Updates in AL Amyloidosis and Light Chain Deposition Disease in... · Comenzo RL et al. EHA Annual Meeting, 2019 • Phase 3 study of daratumumab SC plus CyBorD vs CyBorD alone •

Please pass captcha verification before submit form